STOCK BROKER REVIEW | INVESTING | UPCOMING IPO | ALGO TRADING | TECHNICAL ANALYSIS

Concord Biotech Limited IPO Subscriptions Status Live Today

 

Get Real-Time Updates on stock market trends and news

Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.

Join WhatsApp Channel

Concord Biotech Limited IPO

August 04, 2023 - August 08, 2023 Closed

Concord Biotech Limited IPO Details

Issue Open

04 August 2023

Issue Close

08 August 2023

IPO Price

₹705 - ₹741 per equity share

Face Value

₹1 per equity share

IPO Size

₹1551Cr.

Listing At

NSE, BSE

IPO Lot Size

20 Shares

IPO Investor Categories


• Qualified Institutional Buyers (QIB)- Qualified Institutional Buyers (QIBs) are typically large, financially sophisticated investors, such as mutual funds, insurance companies, pension funds, and hedge funds, who are considered to have the expertise and resources to evaluate investment opportunities. QIBs are required to meet certain financial criteria set by the Securities and Exchange Board of India (SEBI) to participate in an IPO, and they are allowed to bid for shares at a price lower than the price at which shares are offered to retail investors.


• Non-Institutional Investors (NII) - Non-Institutional Investors (NIIs), on the other hand, are typically individual investors, High Net Worth Individuals (HNIs), or corporate bodies who do not meet the financial criteria to be classified as QIBs. They are allowed to participate in an IPO at the same price as retail investors.


NII category has two subcategories:


1. sNII - "sNII" stands for "Small Non-Institutional Investor." This subcategory includes investors who have bid for shares worth between Rs. 2 lakhs and Rs. 10 lakhs in an IPO.


2. bNII - "bNII" stands for "Big Non-Institutional Investor." This subcategory includes investors who have bid for shares worth more than Rs. 10 lakhs in an IPO.


• Retail Individual Investors (RII) - Retail Individual Investors (RIIs) are individual investors who apply for shares worth up to Rs. 2 lakhs in an IPO, aimed at encouraging retail participation in the IPO process.


• Employee (EMP)- The Employee (EMP) category in an IPO is reserved for the employees, directors, and business associates of the issuer company, and the allocation of shares to this category is determined by the issuer company and the lead manager of the IPO.

• Others- A category of eligible shareholders or other investors who have a reserved quota in the IPO.




Frequently Asked Question

Concord Biotech Limited IPO is going to open on 04 August 2023.
Concord Biotech Limited IPO shares will get listed at NSE and BSE.
Link Intime India Private Limited is the registrar of Concord Biotech Limited IPO.
Concord Biotech Limited IPO will get listed on August 18, 2022.
You will receive the allotted shares in your Demat account on August 17, 2023.
Price of 1 share of Concord Biotech Limited IPO is ₹705 - ₹741.
The meaning of "Concord Biotech Limited IPO" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Concord Biotech Limited IPO on the current day.
You can apply for an IPO from any place by using the internet as it is an online process. You can apply for an IPO using 2 methods i.e., ASBA and UPI. ASBA facility is provided by your bank and UPI method is offered by your stock broker. You can invest in Concord Biotech Limited IPO by using any one of these methods at your convenience.
Pre-issue shareholdings of Concord Biotech Limited IPO promoters are 78.83%
If you do not get the allotment of Concord Biotech Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Market lot size of the Concord Biotech Limited IPO is 20 shares.
Concord Biotech Limited IPO will be closed on 08 August 2023.
Face value of equity shares of Concord Biotech Limited IPO is ₹1.
Post-issue shareholdings of concord biotech ltd ipo promoters are 64.03%.
Comments for Concord Biotech Limited IPO Subscriptions Status Live Today

0 comments